Follow-up surveillance strategies for genitourinary malignancies

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


BACKGROUND. Genitourinary cancers account for more than 20% of all malignancies in the United States. These cancers do not usually yield rapid mortality, thereby necessitating longer-term surveillance strategies. METHODS. A review and analysis of relevant studies were performed. Follow-up strategies are proposed to reflect effective methods to detect recurrent prostate, bladder, renal, and testicular cancers. Cost analysis was performed using Medicare reimbursement rates. RESULTS. For genitourinary tumors, follow-up tests can be planned rationally based on detection rates and patterns. Tumor grade and stage drive follow-up strategies, along with therapeutic implications of detecting a recurrence. Symptomatic recurrences often obviate the need for radiographic tests and can minimize costs. Stage-specific plans for these four urologic malignancies are outlined specifically. CONCLUSIONS. Not all surveillance approaches have been critically tested for follow-up of genitourinary tumors, but ample data are available to propose sound medical and economic strategies.

Original languageEnglish (US)
Pages (from-to)2892-2905
Number of pages14
Issue number11
StatePublished - Jun 1 2002


  • Bladder cancer
  • Cancer surveillance
  • Prostate cancer
  • Renal cell cancer
  • Testicular cancer
  • Urologic cancer follow-up

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Follow-up surveillance strategies for genitourinary malignancies'. Together they form a unique fingerprint.

Cite this